Company · CIK 0001739614
Inhibrx, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
CA
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AInhibrx, Inc.0001193125-24-258731 · 59.6 KBSEC(opens sec.gov)
- SC 13G/AInhibrx, Inc.0000905148-24-001668 · 427.7 KBSEC(opens sec.gov)
- 4Insider trades0000950170-24-067359 · 5.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-066650 · 363.3 KBSEC(opens sec.gov)
- 3Inhibrx, Inc.0000950142-24-001419 · 4.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-065125 · 238.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-063107 · 240.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001739614-24-000031 · 285.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001739614-24-000029 · 5.6 MBSEC(opens sec.gov)
- 8-KCurrent report0000950142-24-001307 · 226.6 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA, CA, 92037
mailing
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA, CA, 92037
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies